Literature DB >> 18374015

Reliability of the assessment of lumbar range of motion and maximal isometric strength in patients with chronic low back pain.

Nathalie A Roussel1, Steven Truijen, Ilse De Kerf, Dirk Lambeets, Jo Nijs, Gaëtane Stassijns.   

Abstract

OBJECTIVE: To examine the interobserver reliability of the assessment of lumbar range of motion (ROM) and maximal isometric strength in patients with chronic low back pain (CLBP) using commercially available equipment.
DESIGN: A prospective repeated-measures design.
SETTING: Ambulatory care in a university hospital. PARTICIPANTS: Twelve patients (5 men, 7 women; age range, 20-52y) with CLBP, with a mean visual analog scale score of 31.5+/-25.8mm, volunteered for the study. The duration of their symptoms was 63+/-115 months and the mean Oswestry Disability Index score was 31%.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Movements of the lumbar spine were assessed with commercially available equipment. Both the range of motion (ROM) and the maximal isometric strength for flexion, extension, lateroflexion, and rotation of the lumbar spine were evaluated twice to analyze the interobserver reliability. The same test procedure was performed on 2 separate days by 2 investigators who were blinded to the outcome of the assessment of their colleague. The order of investigator was balanced, so that each investigator tested the same number of patients as first investigator.
RESULTS: The intraclass correlation coefficient varied between .91 and .98 for the measurements of the lumbar ROM and was between .93 and .97 for all the strength measurements. Post hoc power analysis confirmed previous power analysis, that is, despite the small sample size, an excellent power was found for the observed interobserver reliability coefficients (power range, 0.93-1.00). No learning effect was found when comparing the results of the second measurement with the first measurement (P>.05).
CONCLUSIONS: The interobserver reliability is excellent for the measurement of the ROM of the lumbar spine and for the maximal isometric strength using specific devices in patients with CLBP.

Entities:  

Mesh:

Year:  2008        PMID: 18374015     DOI: 10.1016/j.apmr.2007.09.039

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Examination of the Lumbar Movement Pattern during a Clinical Test and a Functional Activity Test in People with and without Low Back Pain.

Authors:  Andrej V Marich; Ching-Ting Hwang; Christopher J Sorensen; Linda R van Dillen
Journal:  PM R       Date:  2019-09-03       Impact factor: 2.298

2.  Practicable performance-based outcome measures of trunk muscle strength and their measurement properties: A systematic review and narrative synthesis.

Authors:  Shouq Althobaiti; Alison Rushton; Ahmad Aldahas; Deborah Falla; Nicola R Heneghan
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

3.  Characteristics of Back Muscle Strength in Patients with Scheduled for Lumbar Fusion Surgery due to Symptomatic Lumbar Degenerative Diseases.

Authors:  Won Hah Park; Chong Suh Lee; Kyung Chung Kang; Yong Gon Seo
Journal:  Asian Spine J       Date:  2014-10-18

4.  Lumbar Extensor Muscle Size and Isometric Muscle Strength in Women with Symptomatic Lumbar Degenerative Diseases.

Authors:  Yong Gon Seo; Won Hah Park; Chong Suh Lee; Kyung Chung Kang
Journal:  Asian Spine J       Date:  2018-09-10

5.  Features of trunk muscle weakness in patients with ankylosing spondylitis: A cross-sectional study.

Authors:  Chin-Man Wang; Wei-Hsien Hong; Huei-Huang Ho; Ji-Yih Chen; Yu-Lin Tsai; Yu-Cheng Pei
Journal:  Biomed J       Date:  2019-05-07       Impact factor: 4.910

6.  The effects of the Mulligan Sustained Natural Apophyseal Glide (SNAG) mobilisation in the lumbar flexion range of asymptomatic subjects as measured by the Zebris CMS20 3-D motion analysis system.

Authors:  Maria Moutzouri; Evdokia Billis; Nikolaos Strimpakos; Polixeni Kottika; Jacqueline A Oldham
Journal:  BMC Musculoskelet Disord       Date:  2008-10-01       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.